Brief: Amphastar Pharmaceuticals Q3 EPS USD 0.37
06/11/2025 21:05
Nov 06 (Reuters) - Amphastar Pharmaceuticals Q3 revenue USD 191.84 million vs. IBES estimate USD 187 million. Q3 adjusted net income USD 44.696 million vs. IBES estimate USD 41.9 million Q3 adjusted EPS USD 0.93 vs. IBES estimate USD 0.85 Q3 net income USD 17.35 million
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray